The global proteomics sector is currently experiencing substantial development, driven by increasing demand for customized medicine and a wider understanding of disease processes. Emerging trends point towards a shift toward large-scale proteomics workflows, particularly supported by advancements in mass detection technology. Furthermore, the expan